Pressreleases

MEDIDATA @ DIA EuroMeeting

MEDIDATA is proud to be a part of Europe's annual DIA meeting.

CoreLab Partners Launches Advanced Imaging Application

CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine.

Euroscreen Announces Global Diabetes Collaboration with Ortho-McNeil-Janssen Pharmaceuticals

Euroscreen announced today that it has entered into a worldwide collaboration and licensing agreement with Ortho-McNeil-Janssen Pharmaceuticals.

Alliance Life Sciences Selects CPR Strategic Marketing Communications to Lead National Public Relations Campaign

Alliance Life Sciences Consulting Group, Inc., a leading management and technology consultancy recognized for defining, deploying and supporting business critical applications, has chosen CPR Strategic Marketing Communications to direct its business-to-business public relations and marketing communications initiatives.

Lonza Selects IDBS to Optimise Bioprocess Execution and Knowledge Management

Lonza has chosen IDBS, a leading global provider of data management and analytics solutions to R&D and healthcare organisations, to provide an electronic data management and execution solution for mammalian cell culture process development. Lonza, a world leader in biopharmaceutical development and production, will deploy IDBS’s Bioprocess Execution System to optimise the management of process development data and drive operational excellence to Lonza customers.

311 Companies Use ILS to Recruit Investigators

Investigator Location Services, Inc. (ILS), the largest study broker, reported the operational results since the companies launch in July 2001. 311 sponsor and CRO companies have used ILS to recruit over 7200 investigators on 700+ protocols including difficult to place projects. ILS investigator recruiting services are free to sponsors and CROs as investigators pay ILS fees.

Lonza Announces New Head of Lonza Life Science Ingredients

Lonza announces the appointment of Harry Boot as new chief operating officer for Lonza’s Life Science Ingredients (LSI) sector and member of the Lonza Management Committee. He takes over the position from Stefan Borgas who headed the sector ad interim since June 2010, parallel to his CEO position. Harry Boot will assume the role on 1 March 2011.

New Product Portfolio: Chemically Defined Supplements

Sheffield Bio-Science adds chemically defined supplements to product portfolio.

Sheffield Bio-Science Wins 2010 Lilly Global Supplier Award

Sheffield Bio-Science, a leading global pharmaceutical supplier of superior quality cell nutrition and excipient products for the biotech and pharmaceutical markets, has been awarded the distinguished 2010 Lilly Global Supplier Award.